Why Australians and New Zealanders fly overseas for dental work: the demand-side explanation

Disclosure. Dr. Maloney has no commercial relationship with any clinic, marketplace, insurer, government agency, or political party named or referenced in this piece. She is a registered specialist endodontist describing a demand pattern, not advocating or recommending overseas treatment. The publication’s standing disclosures (default: none) are documented at /disclosures/. Last reviewed: 2026-06-18.

Most writing about dental tourism starts with the destination: the clinic in Ho Chi Minh City, the price list from Antalya, the before-and-after photos from Bangkok. This piece starts at the other end, at home, because the destination is the effect and the cause is domestic. An Australian or New Zealand patient does not board a flight because a clinic abroad ran a clever campaign. She boards it because the Australian Institute of Health and Welfare reports roughly one in three Australian adults deferring dental care over cost, because the public waiting list is the only subsidised pathway and it is measured in months to years, and because the private quote in front of her is a number no insurance she holds will meaningfully reduce. The trip is rational because the local system left her with no covered alternative. This is the bridge: the local failure is the reason the flight looked rational.

I am a registered specialist endodontist. I am not advocating overseas treatment and I am not condemning it. My job in this piece is to connect two bodies of work this publication produces: the domestic-crisis analysis, which explains why the demand exists, and the dental tourism analysis, which examines what the demand runs into when it lands. Read on its own, each half is incomplete. The cost references read like a complaint without the destination. The clinic and trust-gap pieces read like a warning without the reason anyone takes the risk. Held together, they are one thesis: a coverage failure at home produces a demand the patient then has to navigate abroad, and the patient most driven by the failure is the one least equipped for the navigation.

The cause, in three parts

The domestic engine has three components, and the overseas trip becomes rational only when all three are present at once.

The coverage gap. In Australia, Medicare covers almost no adult dental care, a structure that has held since dental was removed from the public scheme in 1981, set out in full in Medicare’s 1981 dental exclusion and what it costs patients. In New Zealand, public funding follows children to 18 and then stops, set out in New Zealand’s dental crisis: free until 18, unaffordable after and the adult dental gap in New Zealand. Private insurance in both countries caps annual dental benefit below the cost of a single major procedure. The gap is the first component: there is no covered way to pay for the work.

The waiting list. The only subsidised pathway for an eligible adult is public dental, and in most Australian states the non-emergency wait runs to months or years, documented in Australia’s public dental waiting lists, state by state, with eligibility gated to concession holders so that the working poor are not even on a list. New Zealand’s adult public pathway is narrower still, mostly emergency extraction. The waiting list is the second component: it converts the cost crisis into a time crisis, and it offers removal where the patient needs restoration.

The out-of-pocket bill. The full private price lands entirely on the patient. The numbers are in the Australian cost reference and the New Zealand cost reference: a molar root canal and crown at roughly $3,500–$4,900 AUD, a single implant at $4,500–$7,000, a full-arch reconstruction at $18,000–$35,000 per arch, with the New Zealand figures close behind in NZD. The bill is the third component: it is large, it is unsubsidised, and for the complex deferred case it is very large.

Put the three together and the overseas option is not a luxury or an adventure. It is the only path to a fixed outcome that some patients can actually reach. The Chrisopoulos et al. survey (2018: PMID 29378265) in Australia and the Schluter et al. survey (2017: PMID 28753368) in New Zealand both document the deferred-care population the three components produce. That population is the demand pool. It is not produced by a marketing department abroad. It is produced by a coverage architecture at home.

Why the price comparison is real but incomplete

The arithmetic that produces the trip is genuine, and a piece that denied it would not be honest. A full-arch quote of $24,000–$42,000 AUD at home against a mid-tier overseas quote of roughly US$11,000–$14,000 produces a differential larger than any reasonable trip cost. The implant fixture is often the same brand. The differential is in labour cost, real-estate cost, and regulatory overhead between high-cost and low-cost economies, not in the physical object placed in the mouth. The maths, on materials and chair time, works. I have set this out in full in the dental care access crisis long read.

What the price comparison does not capture is the part that determines whether the result is still there at year five: case selection, imaging discipline, prosthetic planning, parafunction screening, the aftercare protocol, and the willingness to refuse a case that should be refused. These are not the fixture. They are the clinical decision architecture around it, they vary within every country as well as between countries, and they are the variable the patient cannot price from the outside. The WHO’s framing of quality of care is the structural reference for why this dimension is the one that matters and the hardest to evaluate. The honest comparison is therefore not price against price. It is price-plus-risk against price-plus-risk, and the risk side is the side the patient cannot see in the quote.

This is where the bridge crosses into the tourism spine. The reason the trip looked rational is documented in the domestic-crisis content. What the trip runs into is documented in the tourism content: the dental tourism trust gap, which explains why the patient cannot evaluate a clinic from outside; when to go overseas for dental treatment and when not to, which gives the four-filter decision framework; and the records and continuity-of-care pieces on what to obtain before leaving, such as the records to obtain before leaving a dental clinic abroad.

The mismatch the bridge exists to name

Here is the fact the bridge exists to make unavoidable, and the one the publication will not resolve into a recommendation. The patient most strongly driven to overseas treatment by the domestic crisis is, on average, the patient least suited to it clinically.

The crisis pushes hardest on the patient with the complex, long-deferred case (because the cost is why she deferred), with limited financial buffer (because the cost is why she is choosing the cheaper market), without a domestic specialist second opinion (because she cannot easily afford the consult, or has already booked), and drawn to the cheapest quotes (because she has the least margin). That same profile is the one for whom a complication is most likely, because the case is complex, and most catastrophic, because the buffer to absorb an unbudgeted redo, return flight, and lost income is not there. The patient for whom the overseas trip is most defensible is the mirror image: a single well-defined procedure, a financial buffer, a second opinion obtained, time for proper staging and recovery. The crisis selects for the first profile. The defensible trip requires the second.

I am not telling the cost-deferred patient not to go. The decision is hers, in a structural environment she did not build, and the domestic alternative is, for many, financially impossible, which means a reflexive “stay home” is advice that ignores her actual situation. I am telling her the truth the marketing copy will not: that the maths-works calculation is different for the two profiles, and that the calculation applying to her specific case may not be the one the price list implies. That honest self-assessment is the protective step the publication cannot take for her, and it is the hinge on which the whole bridge turns.

What we do not yet know, and what would change the view

I hold this account on the published deferred-care data in both countries, the documented coverage structures, the price-differential arithmetic in the publication’s cost references, and my own caseload of returned-from-overseas cases, which is consistent with the patient-mismatch the structural argument predicts. The evidence that would most sharpen it is a multi-country prospective cohort comparing five-year outcomes in cost-deferred patients who used overseas treatment against matched cost-deferred patients who found domestic financing or deferred further, stratified by case complexity, source-market income, and destination, with endpoints on implant survival, complication cost, and patient-reported outcome. No such cohort exists in the published literature to my knowledge. Until it does, the mismatch is an argument from structure and clinical observation, not from a controlled comparison, and I would revise it if a well-designed cohort showed cost-deferred overseas patients doing as well as the defensible-profile patients.

The change that would retire the bridge entirely is the one this publication describes but does not advocate: bringing adult dental care into the public systems of Australia and New Zealand on terms equivalent to medical care. That would shrink the demand pool at its source, because the demand is a coverage artifact. That is a question for governments and electorates. Until then, the cause stays at home and the effect keeps boarding the flight, and the most useful thing this publication can do is make the navigation honest for the patient who is in the only situation she is actually in.

For the policy origin in Australia, see Medicare’s 1981 dental exclusion and the public dental waiting lists, state by state. For New Zealand, see free until 18, unaffordable after and the adult dental gap. For the cost data, see Australia and New Zealand. For the four-country structural frame, see the dental care access crisis long read. For what the trip runs into, see the dental tourism trust gap and when to go overseas for dental treatment and when not to.